Active antithrombin glycoforms are selectively physiosorbed on plasma extracellular vesicles
Abstract Antithrombin (AT) is a glycoprotein produced by the liver and a principal antagonist of active clotting proteases. A deficit in AT function leads to AT qualitative deficiency, challenging to diagnose. Here we report that active AT may travel physiosorbed on the surface of plasma extracellul...
| Published in: | Journal of Extracellular Biology |
|---|---|
| Main Authors: | Annalisa Radeghieri, Silvia Alacqua, Andrea Zendrini, Vanessa Previcini, Francesca Todaro, Giuliana Martini, Doris Ricotta, Paolo Bergese |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-09-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jex2.57 |
Similar Items
Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods
by: Réka Gindele, et al.
Published: (2021-04-01)
by: Réka Gindele, et al.
Published: (2021-04-01)
Antithrombin supplementation to prevent venous thromboembolism: A case of hereditary antithrombin deficiency with increased antithrombin clearance during pregnancy and peripartum
by: Ayako Kaneda-Takeuchi, et al.
Published: (2025-06-01)
by: Ayako Kaneda-Takeuchi, et al.
Published: (2025-06-01)
Interaction of Extracellular Vesicles with Si Surface Studied by Nanomechanical Microcantilever Sensors
by: Stefania Federici, et al.
Published: (2018-03-01)
by: Stefania Federici, et al.
Published: (2018-03-01)
TESTING ANTITHROMBIN LEVEL ALLOWS PREDICTING A CLINICAL OUTCOME OF SEPSIS
by: I. V. Redkin, et al.
Published: (2018-07-01)
by: I. V. Redkin, et al.
Published: (2018-07-01)
Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin
by: Hideo Wada, et al.
Published: (2023-01-01)
by: Hideo Wada, et al.
Published: (2023-01-01)
Transient deficiency of antithrombin during pregnancy in a woman with a history of reproductive losses
by: L. O. Buzyan, et al.
Published: (2018-08-01)
by: L. O. Buzyan, et al.
Published: (2018-08-01)
Antithrombin, COVID-19, and Fresh Frozen Plasma Treatment
by: Rujittika Mungmunpuntipantip, et al.
Published: (2021-06-01)
by: Rujittika Mungmunpuntipantip, et al.
Published: (2021-06-01)
Management of antithrombin III deficiency in pregnancy: a representative case and a literature review
by: S. V. Akinshina, et al.
Published: (2021-09-01)
by: S. V. Akinshina, et al.
Published: (2021-09-01)
Antithrombin activity is a significant predictor of early mortality in pulmonary embolism patients
by: Džudović Boris, et al.
Published: (2022-01-01)
by: Džudović Boris, et al.
Published: (2022-01-01)
Supplementation therapy with Antithrombin Drugs in the Combined Treatment of Sepsis
by: I. V. Redkin, et al.
Published: (2019-11-01)
by: I. V. Redkin, et al.
Published: (2019-11-01)
Prognostic Significance of Antithrombin Activity in Patients with Crimean-Congo Hemorrhagic Fever
by: Mustafa Usanmaz, et al.
Published: (2011-08-01)
by: Mustafa Usanmaz, et al.
Published: (2011-08-01)
Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
by: Hayakawa M
Published: (2017-12-01)
by: Hayakawa M
Published: (2017-12-01)
Use of Antithrombin and Thrombomodulin in the Management of Disseminated Intravascular Coagulation in Patients with Acute Cholangitis
Published: (2013-05-01)
Published: (2013-05-01)
Identification of two point mutations associated with inherited antithrombin deficiency
by: Shiue-Wei Lai, et al.
Published: (2024-12-01)
by: Shiue-Wei Lai, et al.
Published: (2024-12-01)
Evaluation of Serum Level of Thrombin-antithrombin III in Preterm Labors
by: Minoo Movahedi, et al.
Published: (2012-03-01)
by: Minoo Movahedi, et al.
Published: (2012-03-01)
Relationship between Antithrombin III Activity and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
by: Shuling Zhang, et al.
Published: (2022-12-01)
by: Shuling Zhang, et al.
Published: (2022-12-01)
Evaluation of the level of antithrombin in patients with glomerulonephritis and nephrotic syndrome: A cross-sectional study
by: I. Mykhaloiko, et al.
Published: (2024-10-01)
by: I. Mykhaloiko, et al.
Published: (2024-10-01)
Sulfated cellulose thin films with antithrombin affinity
Published: (2009-11-01)
Published: (2009-11-01)
Decreased antithrombin activity in the early phase of trauma is strongly associated with extravascular leakage, but not with antithrombin consumption: a prospective observational study
by: Hironori Matsumoto, et al.
Published: (2018-08-01)
by: Hironori Matsumoto, et al.
Published: (2018-08-01)
Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells
by: Julia Peñas-Martínez, et al.
Published: (2021-05-01)
by: Julia Peñas-Martínez, et al.
Published: (2021-05-01)
Comparative study of chromatographic properties of affinity resins in respect of protein of antithrombin III
by: М. А. Аzhigirova, et al.
Published: (2010-04-01)
by: М. А. Аzhigirova, et al.
Published: (2010-04-01)
Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency
by: Han-lu Wang, et al.
Published: (2023-01-01)
by: Han-lu Wang, et al.
Published: (2023-01-01)
Successful use of an antithrombin for heparin resistance with andexanet alfa
by: Jun Honda, et al.
Published: (2023-05-01)
by: Jun Honda, et al.
Published: (2023-05-01)
The Prognostic Value of Antithrombin Levels in COVID-19 Patients on Intensive Care Unit Admission
by: İlkay Anaklı, et al.
Published: (2024-06-01)
by: İlkay Anaklı, et al.
Published: (2024-06-01)
A successful outcome of pregnancy in a patient with congenital antithrombin deficiency
by: Kovač Mirjana, et al.
Published: (2011-01-01)
by: Kovač Mirjana, et al.
Published: (2011-01-01)
Influence of high‐dose antithrombin on platelet function and blood coagulation
by: Toru Miike, et al.
Published: (2021-01-01)
by: Toru Miike, et al.
Published: (2021-01-01)
Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis
by: Takaaki Totoki, et al.
Published: (2024-01-01)
by: Takaaki Totoki, et al.
Published: (2024-01-01)
Protein C and antithrombin III deficiency in an elderly patient presenting with pulmonary embolism
by: R. Khan, et al.
Published: (2025-08-01)
by: R. Khan, et al.
Published: (2025-08-01)
Role of new oral antithrombin in management of thrombophilia presented with multiple infarctions (cerebral, myocardial and pulmonary embolism)
by: Mohamed Abdelwahab, et al.
Published: (2015-01-01)
by: Mohamed Abdelwahab, et al.
Published: (2015-01-01)
Storage Stability of Blood Samples for miRNAs in Glycosylated Extracellular Vesicles
by: Cuidie Ma, et al.
Published: (2023-12-01)
by: Cuidie Ma, et al.
Published: (2023-12-01)
Combination of antithrombin and soluble thrombomodulin for early prediction of sepsis-Induced disseminated intravascular coagulation
by: Huan Zeng, et al.
Published: (2025-10-01)
by: Huan Zeng, et al.
Published: (2025-10-01)
Effect of frozen storage conditions on antithrombin protein C and protein S activity assay stability
by: Houmei Feng, et al.
Published: (2024-07-01)
by: Houmei Feng, et al.
Published: (2024-07-01)
Association of COVID-19 Vaccines ChAdOx1-S and BNT162b2 with Circulating Levels of Coagulation Factors and Antithrombin
by: Amal Hasan, et al.
Published: (2022-07-01)
by: Amal Hasan, et al.
Published: (2022-07-01)
Differential Protein and Glycan Packaging into Extracellular Vesicles in Response to 3D Gastric Cancer Cellular Organization
by: Álvaro M. Martins, et al.
Published: (2023-08-01)
by: Álvaro M. Martins, et al.
Published: (2023-08-01)
The impact of antithrombin III supplementation on prognosis during extracorporeal membrane oxygenation: a systematic review and meta-analysis
by: Ya-Ting Zeng, et al.
Published: (2025-12-01)
by: Ya-Ting Zeng, et al.
Published: (2025-12-01)
The Effect of Postoperative Antithrombin Supplementation on the Inflammatory and Coagulation Status of a Surgically Treated Patient With a Malignant Tumor in the Small Pelvis—Case Series
by: Ranko Lazović, et al.
Published: (2025-06-01)
by: Ranko Lazović, et al.
Published: (2025-06-01)
Evaluation of Antithrombin-III Deficiency and Factor V Leiden Mutation in Patients with Stroke in Young Patients
by: Hamad Khan, et al.
Published: (2024-06-01)
by: Hamad Khan, et al.
Published: (2024-06-01)
Effect of plasma thrombin-antithrombin complex on ischemic stroke: a systematic review and meta-analysis
by: Peipei Song, et al.
Published: (2023-02-01)
by: Peipei Song, et al.
Published: (2023-02-01)
Combined life-threatening thromboses and hemorrhages in a patient with afibrinogenemia and antithrombin deficiency
by: S. Le Quellec, et al.
Published: (2018-04-01)
by: S. Le Quellec, et al.
Published: (2018-04-01)
Effects of sample matrix in the measurement of antithrombin by LC-MS: A role for immunocapture
by: M. Kruijt, et al.
Published: (2023-01-01)
by: M. Kruijt, et al.
Published: (2023-01-01)
Similar Items
-
Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods
by: Réka Gindele, et al.
Published: (2021-04-01) -
Antithrombin supplementation to prevent venous thromboembolism: A case of hereditary antithrombin deficiency with increased antithrombin clearance during pregnancy and peripartum
by: Ayako Kaneda-Takeuchi, et al.
Published: (2025-06-01) -
Interaction of Extracellular Vesicles with Si Surface Studied by Nanomechanical Microcantilever Sensors
by: Stefania Federici, et al.
Published: (2018-03-01) -
TESTING ANTITHROMBIN LEVEL ALLOWS PREDICTING A CLINICAL OUTCOME OF SEPSIS
by: I. V. Redkin, et al.
Published: (2018-07-01) -
Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin
by: Hideo Wada, et al.
Published: (2023-01-01)
